🇺🇸 FDA
Pipeline program

ASTX727, Venclyxto 50 mg film-coated tablets, Venclyxto 10 mg film-coated tablets, Venclyxto 100 mg film-coated tablets

ASTX727-07

Phase 2 small_molecule active

Quick answer

ASTX727, Venclyxto 50 mg film-coated tablets, Venclyxto 10 mg film-coated tablets, Venclyxto 100 mg film-coated tablets for Acute Myeloid Leukemia (AML) is a Phase 2 program (small_molecule) at Taiho Pharma Netherlands B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Taiho Pharma Netherlands B.V.
Indication
Acute Myeloid Leukemia (AML)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials